Literature DB >> 18234315

Primary resistance to imatinib in Fip1-like 1-platelet-derived growth factor receptor alpha-positive eosinophilic leukemia.

Dagmar Simon, Souzan Salemi, Shida Yousefi, Hans-Uwe Simon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18234315     DOI： 10.1016/j.jaci.2007.11.027

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  11 in total

Review 1.  Eosinophilic myeloproliferative disorders.

Authors:  Amy D Klion
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

Review 2.  Therapeutic approaches to patients with hypereosinophilic syndromes.

Authors:  Hans-Uwe Simon; Amy Klion
Journal:  Semin Hematol       Date:  2012-04       Impact factor: 3.851

Review 3.  How I treat hypereosinophilic syndromes.

Authors:  Amy D Klion
Journal:  Blood       Date:  2015-05-11       Impact factor: 22.113

Review 4.  Refining the definition of hypereosinophilic syndrome.

Authors:  Hans-Uwe Simon; Marc E Rothenberg; Bruce S Bochner; Peter F Weller; Andrew J Wardlaw; Michael E Wechsler; Lanny J Rosenwasser; Florence Roufosse; Gerald J Gleich; Amy D Klion
Journal:  J Allergy Clin Immunol       Date:  2010-07       Impact factor: 10.793

Review 5.  Advances in mechanisms of asthma, allergy, and immunology in 2008.

Authors:  Joshua A Boyce; David Broide; Kenji Matsumoto; Bruce S Bochner
Journal:  J Allergy Clin Immunol       Date:  2009-03       Impact factor: 10.793

Review 6.  How I treat hypereosinophilic syndromes.

Authors:  Amy D Klion
Journal:  Blood       Date:  2009-08-19       Impact factor: 22.113

7.  Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.

Authors:  Princess U Ogbogu; Bruce S Bochner; Joseph H Butterfield; Gerald J Gleich; Johannes Huss-Marp; Jean Emmanuel Kahn; Kristin M Leiferman; Thomas B Nutman; Florian Pfab; Johannes Ring; Marc E Rothenberg; Florence Roufosse; Marie-Helene Sajous; Javed Sheikh; Dagmar Simon; Hans-Uwe Simon; Miguel L Stein; Andrew Wardlaw; Peter F Weller; Amy D Klion
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

Review 8.  Novel targeted therapies for eosinophil-associated diseases and allergy.

Authors:  Susanne Radonjic-Hoesli; Peter Valent; Amy D Klion; Michael E Wechsler; Hans-Uwe Simon
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-17       Impact factor: 13.820

9.  Myeloid Neoplasm with PDGFRA Rearrangement Manifesting as a Retromolar Pad Mass.

Authors:  Amy S Duffield; Jonathan Webster; B Douglas Smith; Julius S Necciai; Austin McCuiston; Alisha D Ware
Journal:  Head Neck Pathol       Date:  2021-02-22

Review 10.  Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity.

Authors:  Peter Valent; Lina Degenfeld-Schonburg; Irina Sadovnik; Hans-Peter Horny; Michel Arock; Hans-Uwe Simon; Andreas Reiter; Bruce S Bochner
Journal:  Semin Immunopathol       Date:  2021-05-30       Impact factor: 9.623
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.